ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,993Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 617

$506K Total Retail Price of All Prescriptions

Rank: 96 out of 617

519 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 13,116 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
AMLODIPINE BESYLATE 542 510 1 6
OMEPRAZOLE 536 508 2 3
FUROSEMIDE 522 485 3 4
SIMVASTATIN 519 478 4 2
LEVOTHYROXINE SODIUM 431 412 5 1
HYDROCODONE-ACETAMINOPHEN 359 331 S3 6 8
METOPROLOL TARTRATE 353 341 7 11
WARFARIN SODIUM 351 339 8 7
LISINOPRIL 350 336 9 5
METFORMIN HCL 304 301 10 9
ATORVASTATIN CALCIUM 284 284 11 14
POTASSIUM CHLORIDE 282 266 12 10
PAROXETINE HCL 262 252 13 62
TRAMADOL HCL 231 213 14 15
HYDROCHLOROTHIAZIDE 212 212 15 13
ALENDRONATE SODIUM 186 167 16 25
FENTANYL 183 173 S2 17 45
ZOLPIDEM TARTRATE 176 167 18 23
LOSARTAN POTASSIUM 176 164 18 22
POLYETHYLENE GLYCOL 3350 167 142 20 32
CITALOPRAM HBR 160 150 21 18
PREDNISONE 158 150 22 31
RAMIPRIL 155 155 23 67
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 154 24 29
DILTIAZEM 24HR ER 147 136 25 162
ISOSORBIDE MONONITRATE ER 146 134 26 52
SPIRONOLACTONE 145 123 27 42
GABAPENTIN 144 128 28 16
GLIMEPIRIDE 133 121 29 33
LOSARTAN-HYDROCHLOROTHIAZIDE 115 115 30 46
PANTOPRAZOLE SODIUM 113 113 31 37
METOPROLOL SUCCINATE 110 110 32 12
ATENOLOL 108 108 33 17
ENALAPRIL MALEATE 107 95 34 34
CARVEDILOL 107 95 34 19
TORSEMIDE 96 96 36 110
TAMSULOSIN HCL 93 93 37 26
ALLOPURINOL 91 91 38 27
NAMENDA 85 85 39 35
DONEPEZIL HCL 83 83 40 30
TRIAMTERENE-HYDROCHLOROTHIAZID 81 81 41 122
BYSTOLIC 74 74 42 64
MIRTAZAPINE 74 74 42 50
DILTIAZEM ER 72 72 44 81
NABUMETONE 70 54 45 120
DIGOXIN 69 69 46 48
FLUTICASONE PROPIONATE 68 59 47 36
BISOPROLOL-HYDROCHLOROTHIAZIDE 68 68 47 87
TRIAMTERENE-HCTZ 67 67 49 47
CIPROFLOXACIN HCL 66 59 50 60
ADVAIR DISKUS 66 66 50 38
LEVOFLOXACIN 65 64 52 89
CLOPIDOGREL 61 61 53 53
CARTIA XT 61 57 53 284
TERAZOSIN HCL 55 55 55 96
DILTIAZEM 24HR CD 53 51 56 117
ACTOS 53 53 56 85
LOVASTATIN 51 51 58 57
RISPERIDONE 51 51 58 71
QUINAPRIL HCL 51 51 58 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.